title: Acceptance of FGM or CGM in Clinical Decision-Making and Patient Preference: Where Do We Go from Here?
authors.affiliation: 1 AGP Clinical Academy, Portsmouth Hospitals , NHST, Portsmouth, United Kingdom .|2 Nanjing Medical University , Nanjing, China .
authors.forename: Roger S
authors.initials: RS
authors.lastname: Mazze
mesh_terms: D000203:Activities of Daily Living; D000328:Adult; D001291:Attitude of Health Personnel; D002648:Child; D000066491:Clinical Decision-Making; D003131:Combined Modality Therapy / Q000009:adverse effects; D018795:Device Approval; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy / Q000628:therapy; D016903:Drug Monitoring; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018670:Monitoring, Ambulatory / Q000379:methods* / Q000639:trends; D010342:Patient Acceptance of Health Care; D057240:Patient Preference; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin